Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:50 pm Purchase |
2021-12-31 | 13G | Mereo BioPharma Group plc MREO |
Point72 Asset Management, L.P. | 10,610,000 9.100% |
3,710,331 (+53.78%) |
Filing History |
| 2022-02-14 4:40 pm Sale |
2021-12-31 | 13G | Mereo BioPharma Group plc MREO |
Boxer Capital LLC | 4,082,576 3.600% |
-6,226,674 (-60.40%) |
Filing History |
| 2022-02-14 4:16 pm Purchase |
2021-12-31 | 13G | Mereo BioPharma Group plc MREO |
Baker Bros. Advisors LP | 64,917,601 9.990% |
25,285,672 (+63.80%) |
Filing History |
| 2022-02-14 08:50 am Purchase |
2021-12-31 | 13G | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 74,572,235 13.700% |
18,072,235 (+31.99%) |
Filing History |
| 2022-02-14 06:19 am Sale |
2021-12-31 | 13G | Mereo BioPharma Group plc MREO |
Citadel Advisors LLC | 20,081,572 3.700% |
-10,848,814 (-35.07%) |
Filing History |
| 2022-02-11 5:26 pm Purchase |
2021-12-31 | 13G | Mereo BioPharma Group plc MREO |
Vivo Capital IX, LLC | 9,409,051 7.800% |
448,755 (+5.01%) |
Filing History |
| 2022-02-11 4:37 pm Purchase |
2021-12-31 | 13G | Mereo BioPharma Group plc MREO |
SUVRETTA CAPITAL MANAGEMENT, LLC | 45,710,335 8.400% |
13,882,835 (+43.62%) |
Filing History |
| 2022-02-11 4:31 pm Purchase |
2021-12-31 | 13G | Mereo BioPharma Group plc MREO |
ORBIMED ADVISORS LLC | 6,063,345 5.590% |
1,544,989 (+34.19%) |
Filing History |
| 2021-12-02 2:31 pm Purchase |
2021-09-30 | 13G | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 56,500,000 10.380% |
56,500,000 (New Position) |
Filing History |
| 2021-03-01 5:19 pm Purchase |
2021-02-17 | 13G | Mereo BioPharma Group plc MREO |
Point72 Asset Management, L.P. | 6,899,669 6.400% |
6,899,669 (New Position) |
Filing History |
| 2021-02-19 4:27 pm Purchase |
2021-02-10 | 13G | Mereo BioPharma Group plc MREO |
SUVRETTA CAPITAL MANAGEMENT, LLC | 31,827,500 5.900% |
31,827,500 (New Position) |
Filing History |
| 2021-02-16 4:53 pm Purchase |
2020-12-31 | 13G | Mereo BioPharma Group plc MREO |
Baker Bros. Advisors LP | 39,631,929 11.400% |
39,631,929 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | Mereo BioPharma Group plc MREO |
Vivo Capital IX, LLC | 8,960,296 8.168% |
-21,635,328 (-70.71%) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | Mereo BioPharma Group plc MREO |
Citadel Advisors LLC | 30,930,386 8.900% |
-202,605 (-0.65%) |
Filing History |
| 2021-02-16 4:29 pm Sale |
2020-12-31 | 13G | Mereo BioPharma Group plc MREO |
Boxer Capital LLC | 10,309,250 9.100% |
-10,052,625 (-49.37%) |
Filing History |
| 2021-02-12 5:00 pm Purchase |
2020-12-31 | 13G | Mereo BioPharma Group plc MREO |
ORBIMED ADVISORS LLC | 4,518,356 6.660% |
4,518,356 (New Position) |
Filing History |
| 2020-07-10 4:30 pm Purchase |
2020-06-30 | 13G | Mereo BioPharma Group plc MREO |
Vivo Capital IX, LLC | 30,595,624 9.000% |
16,480,873 (+116.76%) |
Filing History |
| 2020-07-10 4:02 pm Purchase |
2020-07-01 | 13G | Mereo BioPharma Group plc MREO |
Citadel Advisors LLC | 31,132,991 8.900% |
31,132,991 (New Position) |
Filing History |
| 2020-07-10 10:48 am Sale |
2020-06-30 | 13G | Mereo BioPharma Group plc MREO |
BLACKROCK INC BLK |
0 0.000% |
-16,478,248 (Position Closed) |
Filing |
| 2020-07-02 06:19 am Purchase |
2020-06-30 | 13G | Mereo BioPharma Group plc MREO |
Aspire Capital Fund LLC | 20,680,882 6.110% |
20,680,882 (New Position) |
Filing History |